The fluctuating gastrointestinal milieu and its restrictive epithelial barrier represent critical challenges for the design of oral cancer vaccines. Nevertheless, leveraging the gut microbiome as an interventional strategy has recently gained traction, especially in patients on immune checkpoint inhibitor (ICI) therapy...
Wen-Fei Chen, Fan Yang, Bei-Bei Wu et al.· Advances in Materials· 0 citations
The gut-liver axis is a central conduit through which intestinal immunity and metabolism regulate liver health. Although gut probiotics such as Parabacteroides distasonis (P. distasonis) and their postbiotics show promise for treating related disorders, safety and stability concerns and inconsistent efficacy limit thei...
HF mortality may arise from the convergence of myocardial injury and systemic biological aging, and proteomic and metabolomic approaches are promising tools for identifying molecular phenotypes, although assay heterogeneity, insufficient age-specific validation, uncertain incremental clinical utility, and limited bedsi...
Xiao-Feng Zeng, W. Cheng, Yan Jiang et al.· Frontiers in Cardiovascular...· 1 citation
ML models show promising discriminative performance for DKD prediction, but the evidence is severely limited by high heterogeneity, lack of external validation and reporting of calibration metrics, and poor methodological transparency.